Aztreonam
Aztreonam
Aztreonam
Thermo Scientific Chemicals

Aztreonam

CAS: 78110-38-0 | C13H17N5O8S2 | 435.426 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J62887.06
also known as J62887-06
Price (USD)
481.00
Each
Quantity:
5 g
Request bulk or custom format
Price (USD)
481.00
Each
Chemical Identifiers
CAS78110-38-0
IUPAC Name(2S,3S)-3-[(2Z)-2-(2-azaniumyl-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-methyl-4-oxoazetidine-1-sulfonate
Molecular FormulaC13H17N5O8S2
InChI KeyWZPBZJONDBGPKJ-VEHQQRBSSA-N
SMILESC[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
View more
SpecificationsSpecification SheetSpecification Sheet
CommentRelated substances: ≤ 1.5% Individual, ≤ 2.5 % Total
Assay (HPLC)≥92.0%
Heavy Metals≤10 ppm
Optical Rotation- 26° to -32°
Residue on ignition≤ 0.1%
View more
Aztreonam is used to treat severe infections of the urinary tract, lower respiratory tract, skin, stomach, female reproductive organs, and other body systems.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Aztreonam is used to treat severe infections of the urinary tract, lower respiratory tract, skin, stomach, female reproductive organs, and other body systems.

Solubility
Soluble in DMF/water (1:1) at 50 mg/ml

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Keep away from strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Dallal MM.; Czachor JS. Aztreonam-induced myelosuppression during treatment of Pseudomonas aeruginosa pneumonia. DICP. 1991, 25 (6), 594-7.
  2. Kobayashi, Y.; Uchida, H.; Kawakami Y. Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood. J Antimicrob Chemother . 1992, 30 (6), 871-872.